pointed out that in lapatinib-treated HER2+ mammary tumors in MMTV-Neu mice, efferocytosis cleared apoptotic tumor cells, while blockade of efferocytosis induced secondary necrosis of ACs. Here, ERBB2 is linked to breast cancer.